HCA Healthcare Inc. (HCA) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (41% profit margin, 19% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
HCA Healthcare Inc. (HCA) surged +3.21% to $478.08 as options desks priced 56% call premium vs. 44% put protection around the $469 max-pain magnet. High-quality cash engine (41% profit margin, 19% return on capital) with steady institutional support.
Hospital operator HCA Healthcare (NYSE:HCA) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 3.6% year on year to $19.85 billion. The company expects the full year’s revenue to be around
Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while health care posts a record month against the market.
Defensive stocks are having a moment in the sun.
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $496 to $521.
ResMed (NYSE:RMD) reported first-quarter fiscal 2027 revenue of $1.4 billion, up 6% from a year earlier on a reported basis and 7% on a core constant-currency basis, as growth in sleep devices, masks and residential care
Tenet Healthcare's Q3 earnings surge 79.5% on strong hospital performance and cost discipline, prompting higher 2026 EPS and EBITDA guidance.
An increasing shift toward outpatient surgeries and slower-than-expected ramps to profitability at some of its hospitals dinged Universal Health Services’ earnings in the third quarter.
HCA Healthcare’s third quarter results modestly exceeded Wall Street’s expectations, driven by continued growth in demand for its hospital services and improvements in core cost management initiatives. CEO Samuel Hazen a
NASHVILLE, Tenn., October 29, 2026--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that 102 of its hospitals have been recognized by Healthgrades for excellence in spec
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $387 to $401.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +7.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on HCA today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for HCA. Explore sector supply chains on /butterfly.
Why HCA Stock surged +3.21% Today — RQD Quant Desk Flash. High-quality cash engine (41% profit margin, 19% return on capital) with steady institutional support.